Working… Menu

BVD-523 Plus Nab-paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02608229
Recruitment Status : Active, not recruiting
First Posted : November 18, 2015
Last Update Posted : September 24, 2019
BioMed Valley Discoveries, Inc
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Washington University School of Medicine